News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PhytoMedical Technologies, Inc. (PYTO.OB) Renews Sponsored Research Agreement with Dartmouth College



10/6/2008 8:39:28 AM

PRINCETON, N.J.--(BUSINESS WIRE)--PhytoMedical Technologies, Inc. (OTCBB: PYTO) (FWB: ET6), today announced that it is renewing its Sponsored Research Agreement with Dartmouth College. “I am extremely pleased to have extended our agreement with Dartmouth College,” stated Mr. Greg Wujek, President and CEO of PhytoMedical Technologies, Inc. “This past year, Dr. Gordon Gribble and his staff have worked very hard to assure all of our developmental goals were accomplished on time allowing us to move from the initial human cancer cell line in vitro testing to our current development phase seamlessly.” Dartmouth Technology Transfer Office Assistant Director, Glennis Gold affirmed, “Our collaboration with PhytoMedical is an excellent example of how technology arising out of academia may be transferred to the private sector in order to serve the public good.”

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES